Professor Mark Rosenthal
Director of the Victorian Comprehensive Cancer Centre’s Clinical Trial Unit.
Professor Mark Rosenthal trained as a Medical Oncologist in Melbourne and Sydney, Australia.
He was awarded a Doctorate of Philosophy for a thesis examining the molecular genetics of colon cancer conducted at the Ludwig Institute for Cancer Research (1992-1996).
He completed post-graduate training at New York University Medical Centre, New York, USA (1996-98) and was appointed as a Senior Staff Specialist in the Department of Medical Oncology, Royal Melbourne Hospital in 1998. In 2006, he was appointed Professor Director of the Department and was Chairman and Chief Medical Officer of Cancer Trials Australia until 2016 when he was appointed as Director of the Victorian Comprehensive Cancer Centre Clinical Trials Unit.
He is Chairman of the of the Cooperative Trials Group for Neuro-Oncology (COGNO).
His major interests include: prostate cancer, neuro-oncology and early phase clinical trials.